Contract 36F79718D0456
Melinta Therapeutics, Llc · Department Of Veterans Affairs · September 22, 2021
Melinta Therapeutics, Llc was awarded a federal contract by Department Of Veterans Affairs on September 22, 2021 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on August 14, 2024. If all options are exercised, the contract could reach $4.20 million.
Contract details
- PIID
- 36F79718D0456
- Award type
- —
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- September 22, 2021
- Latest action
- August 14, 2024
Description
CONTRACT CANCELLATION
Modification timeline
-
August 14, 2024Mod P00030 · Legal Contract Cancellation$0
-
September 28, 2021Mod P00014 · Supplemental Agreement For Work Within ScopeADDITION$0
-
September 22, 2021Mod P00013 · Unique Entity Id Or Legal Business Name Change - Non-NovationNAME CHANGE$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Covermymeds Pharmacy Llc | Department Of Veterans Affairs | July 2, 2026 | $16.4K |
| United Therapeutics Corp | Department Of Veterans Affairs | July 2, 2026 | $17.4K |
| Sk Life Science, Inc. | Department Of Veterans Affairs | July 2, 2026 | $0 |
| Theracom, L.L.C. | Department Of Veterans Affairs | July 2, 2026 | $38.1K |
| Cycle Pharmaceuticals Ltd | Department Of Veterans Affairs | July 2, 2026 | $0 |
| Regimed Medical | Department Of Veterans Affairs | July 2, 2026 | $292.9K |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36F79718D0456?
Contract 36F79718D0456 is a federal contract awarded to Melinta Therapeutics, Llc by Department Of Veterans Affairs on September 22, 2021 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 2 times since the base award.
Who won contract 36F79718D0456?
Melinta Therapeutics, Llc won contract 36F79718D0456 from Department Of Veterans Affairs.
How much is contract 36F79718D0456 worth?
Contract 36F79718D0456 has obligated $0 to date but carries a potential ceiling of $4.20 million if fully funded and all options are exercised.